Resveratrol and Angiogenin-2 Combined With PEGDA/TCS Hydrogel for the Targeted Therapy of Hypoxic Bone Defects via Activation of the Autophagy Pathway

The guarantee of cell survival under hypoxic conditions and rapid vascularization is a key in tissue engineering strategies for treating bone defects. Our study aimed to establish the protective role of bone marrow mesenchymal stem cells (BMSCs) and human umbilical vein endothelial cells (HUVECs) in...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Dehui, Liu, Hengping, Zhang, Zhenning, Su, Meiyi, Yuan, Zhixian, Lin, Ying, Yang, Shuquan, Li, Wenqiang, Zhang, Xintao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079142/
https://www.ncbi.nlm.nih.gov/pubmed/33927615
http://dx.doi.org/10.3389/fphar.2021.618724

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079142/
https://www.ncbi.nlm.nih.gov/pubmed/33927615
http://dx.doi.org/10.3389/fphar.2021.618724

Ejemplares similares